Recursion Pharmaceuticals, Inc. (RXRX)
4.405
+0.04
(+1.03%)
USD |
NASDAQ |
Dec 24, 12:59
4.40
0.00 (0.00%)
After-Hours: 13:59
Recursion Pharmaceuticals SG&A Expense (TTM): 220.12M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 10.39B |
| Pfizer Inc. | 13.91B |
| Hims & Hers Health, Inc. | 1.147B |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Amicus Therapeutics, Inc. | 353.07M |